NCT00002806 Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma Status COMPLETED Phase PHASE2
NCT00002754 Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors Status COMPLETED Phase PHASE1
NCT00002753 Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas Status COMPLETED Phase PHASE1
NCT00002752 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT00002647 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Status UNKNOWN Phase PHASE1
NCT00002639 Suramin in Treating Patients With Recurrent Primary Brain Tumors Status COMPLETED Phase PHASE2
NCT00002619 Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors Status COMPLETED Phase PHASE2
NCT00002608 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Status COMPLETED Phase PHASE2
NCT00002572 Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors Status COMPLETED Phase PHASE1
NCT00002569 Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Status COMPLETED Phase PHASE3
NCT00002545 Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00002543 Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer Status COMPLETED Phase N/A
NCT00002472 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors Status COMPLETED Phase PHASE2
NCT00002463 Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Status COMPLETED Phase PHASE2